Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

By Amina Niasse (Reuters) -Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up ...

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

Denmark's Novo Nordisk is partnering with biotech company Deep Apple Therapeutics in a deal worth up to $812 million to ...

Obesity-drug makers have signed deals that could be worth $812 million to a South San Francisco company and more than $650 ...